David A. Sinclair with Matthew D. LaPlante · 2019
Why We Age—and Why We Don't Have To
Rough AI truth score
50/100
Sinclair accurately presents aging as an active biological research frontier involving interconnected cellular mechanisms. The leap from model organisms and biomarkers to human age reversal, resveratrol, NAD boosters, and near-term radical longevity is much less secure.
Based on three central claims · medium-low confidence
The updated hallmarks framework synthesizes extensive evidence that these processes change with age and interact across tissues. It is a research framework rather than a complete causal theory, and manipulating a marker does not necessarily slow organismal aging.
Animal experiments and human lifestyle evidence show modifiable healthspan pathways, making geroscience plausible. Directly proving slowed human aging requires long trials, validated endpoints, and separation from disease-specific effects; current hallmark studies often cannot establish that distinction.
Human trials show that some precursors raise NAD-related metabolites and are tolerated short term, but functional and clinical outcomes are heterogeneous or null. Resveratrol lacks conclusive evidence for recommendation in any healthcare setting, and no trial shows lifespan extension in humans.
What this number means. It is an AI-generated first-pass judgment of three central factual or causal claims—not a rating, exhaustive fact-check, or human peer review. Claim credits are 100% for supported, 75% for mostly supported, 50% for mixed, and 25% for weak, then averaged and rounded. Lower confidence means the score should move more as better evidence arrives.
Method three-central-claims/0.1.0 · checked 2026-09-01 · 3/3 selected claims assessed · method and source audit